LINC00511 and urinary bladder cancer: By inhibiting the Wnt/β-catenin signaling pathway activity, LINC00511 suppression decreases bladder cancer cells ability to proliferate and increases their likelihood of dying. LINC00511 could also be a putative bladder cancer indicator and possible therapeutic target.